[B041] Target analysis
Obtain Target analysis about organization, disease, drug type etc.
Request Parameters
List of parameters supported by this API endpoint
| Name | Type | Example | Description |
|---|---|---|---|
Required | string | 9786d32e3d244a688ec6a60d2fe1b10b | Target ID, obtain this through the target autocomplete interface |
Required | string | ORGANIZATION | Analysis type, enum: ORGANIZATION、DISEASE、DRUG_TYPE |
Required | boolean | true | Should the aggregation start from the headquarters as the root node? true - yes, false - no. The default is true |
Response Schema
Structure of the API response data
| Field Name | Type | Example | Description |
|---|---|---|---|
data | object | - | response data |
disease | array | [
{
"id": "524236920ce94d7d831f0ac59bcacae8",
"phase": [
{
"dev_status": {
"display_name": [
{
"lang": "EN",
"name": "Approved"
},
{
"lang": "CN",
"name": "批准上市"
}
],
"normalized_id": "efd6215835394b07b046125e3175d3fe"
},
"drug_count": 7
}
],
"display_name": [
{
"lang": "EN",
"name": "Hodgkin's Lymphoma"
},
{
"lang": "CN",
"name": "霍奇金淋巴瘤"
}
]
}
] | Disease, Referencing "AnalysisDto" |
id | string | b4c624212749f84e83429c5a8673c692 | ID |
phase | array | [
{
"dev_status": {
"display_name": [
{
"lang": "EN",
"name": "Pending"
},
{
"lang": "CN",
"name": "无进展"
}
],
"normalized_id": "4d95bf5fb0c340fbb38cda626c1c9c60"
},
"drug_count": 10
}
] | Phase, Referencing "PhaseDto" |
dev_status | object | {
"display_name": [
{
"lang": "EN",
"name": "Pending"
},
{
"lang": "CN",
"name": "无进展"
}
],
"normalized_id": "4d95bf5fb0c340fbb38cda626c1c9c60"
} | Dev Status |
display_name | array | [
{
"lang": "EN",
"name": "Autologous CAR-T"
},
{
"lang": "CN",
"name": "自体CAR-T"
}
] | Dict Name |
lang | string | EN | Language |
name | string | Ranibizumab (Genentech) | Drug,Target,Organization,Disease,Country/Location,DICT,Mechanism Action Name |
normalized_id | string | 2fbfdb3e92d942c48cbb0adb79f23526 | Dict ID |
drug_count | integer<int64> | 10 | Drug Count |
display_name | array | [
{
"lang": "EN",
"name": "Roche Holding AG"
},
{
"lang": "CN",
"name": "罗氏"
}
] | Name, Referencing "CommonName" |
drug_type | array | [
{
"id": "c38eb408d6b842f487d6a27484156633",
"phase": [
{
"dev_status": {
"display_name": [
{
"lang": "EN",
"name": "Approved"
},
{
"lang": "CN",
"name": "批准上市"
}
],
"normalized_id": "efd6215835394b07b046125e3175d3fe"
},
"drug_count": 14
}
],
"display_name": [
{
"lang": "EN",
"name": "Monoclonal antibody"
},
{
"lang": "CN",
"name": "单克隆抗体"
}
]
}
] | Drug Type, Referencing "AnalysisDto" |
organization | array | [
{
"id": "391046f8744a1cde275e09de08b483f3",
"phase": [
{
"dev_status": {
"display_name": [
{
"lang": "EN",
"name": "Approved"
},
{
"lang": "CN",
"name": "批准上市"
}
],
"normalized_id": "efd6215835394b07b046125e3175d3fe"
},
"drug_count": 2
}
],
"display_name": [
{
"lang": "EN",
"name": "Akeso Biopharma Co., Ltd."
},
{
"lang": "CN",
"name": "中山康方生物医药有限公司"
}
]
}
] | Organization, Referencing "AnalysisDto" |
statusRequired | boolean | false | Status |
error_msg | string | The request parameter format is incorrect! | Error Message |
error_codeRequired | integer | 0 | Error Code |
Success Response Example
Example of a successful API response
JSON
{
"data": {
"disease": [
{
"id": "b4c624212749f84e83429c5a8673c692",
"phase": [
{
"dev_status": {
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
},
"drug_count": 10
}
],
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
}
],
"drug_type": [
{
"id": "b4c624212749f84e83429c5a8673c692",
"phase": [
{
"dev_status": {
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
},
"drug_count": 10
}
],
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
}
],
"organization": [
{
"id": "b4c624212749f84e83429c5a8673c692",
"phase": [
{
"dev_status": {
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
},
"drug_count": 10
}
],
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
}
]
},
"status": true,
"error_code": 0
}Error Codes
List of possible error codes returned by this endpoint
Business Errors
| Error Code | Description |
|---|---|
68300004 | Invalid parameter! |
68300005 | Search api failure! |
68300006 | Analytic basic access error! |
68300007 | Bad request! |
68300008 | Service error, please try again later! |
68300010 | The file does not comply with upload specifications! |
Platform Errors
| Error Code | Description |
|---|---|
67200001 | API call exceeds the total limit set by the platform! |
67200002 | Quota exceeds the limit! |
67200003 | Access token expired or authentication error! |
67200004 | No permission or API package quota has exceeded the limit! |
67200005 | Insufficient balance, call failed! |
67200006 | This client has expired and call failed! |
67200007 | Exceeded the call limit, call failed! |
HTTP Status Codes
| Status Code | Description |
|---|---|
0 | Success |
401 | Unauthorized |
403 | Forbidden |
404 | Not Found |
Performance Metrics
Expected performance characteristics for this endpoint
Normal Response Time
5000 ms
Max Response Time
10000 ms